Editorial: Immune-checkpoint inhibitors in anti-cancer armamentarium: a double-edged sword in risk of developing autoimmunity and immune-related adverse effects

Bibliographic Details
Title: Editorial: Immune-checkpoint inhibitors in anti-cancer armamentarium: a double-edged sword in risk of developing autoimmunity and immune-related adverse effects
Authors: Aysin Tulunay Virlan, Giacomo Cafaro, Flavia Sunzini, Yannick Degboe, Maria-Ioanna Christodoulou
Source: Frontiers in Oncology, Vol 14 (2024)
Publisher Information: Frontiers Media S.A., 2024.
Publication Year: 2024
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Subject Terms: cancer immunotherapy, immune-checkpoint inhibitors (ICIs), immune-related adverse events (irAEs), autoimmunity, anti-CTLA-4, anti-PD-1/PD-L1, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2234-943X
Relation: https://www.frontiersin.org/articles/10.3389/fonc.2024.1476475/full; https://doaj.org/toc/2234-943X
DOI: 10.3389/fonc.2024.1476475
Access URL: https://doaj.org/article/8701fbbc8a6f429a95a90b958cf6287d
Accession Number: edsdoj.8701fbbc8a6f429a95a90b958cf6287d
Database: Directory of Open Access Journals
More Details
ISSN:2234943X
DOI:10.3389/fonc.2024.1476475
Published in:Frontiers in Oncology
Language:English